The impact of radioligand therapy on prognosis in patients with lung neuroendocrine tumors
RLT demonstrated signals of clinically meaningful activity and an acceptable safety profile in patients with advanced LNETs in this small retrospective cohort. Outcomes were numerically more favorable in individuals with high SSTR uptake and in those treated with tandem therapy, but the study was not designed to compare treatment regimens. These exploratory findings should be regarded as hypothesis-generating only and do not provide evidence of comparative efficacy.
Authors
- Katarzyna Jóźwik−Plebanek (ORCID: https://orcid.org/0000-0002-6756-5415)
- Marek Saracyn
- Mirosław Dziuk (ORCID: https://orcid.org/0000-0001-9993-373X)
- Katarzyna Gniadek-Olejniczak (ORCID: https://orcid.org/0000-0001-8837-8160)
- Adam Daniel Durma (ORCID: https://orcid.org/0000-0001-7103-2577)
- Maciej Kołodziej (ORCID: https://orcid.org/0000-0003-1943-264X)
- Grzegorz Kamiński (ORCID: https://orcid.org/0000-0002-2357-0634)
- Katarzyna Janiak (ORCID: https://orcid.org/0000-0002-0484-7052)
- Weronika Mądra (ORCID: https://orcid.org/0009-0001-1050-2704)
- Zuzanna Balcerska
Institutions
- National Academy of Medicine (US)
- University of Warsaw (PL)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.3389/fendo.2026.1738286
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wojskowy Instytut Medyczny